Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dean Schorno Insider Profile
11 Followers
Dean Schorno, CFO at Genomic Health, holds 402.89K shares in Rigel (Ticker: RIGL), holds 30.67K shares in Genomic Health (Ticker: GHDX). Most recently, Dean Schorno Sold ― shares of Rigel on Feb 06, 2024 for an estimated value of 14.28K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-29.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP & CFO
Roles that Dean Schorno holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dean Schorno
Dean Schorno's Trading History
Genomic Health
Jun 13, 2014
―
Uninformative Sell
110.48K
$1.95M
Rigel
Feb 06, 2024
EVP & CFO
Informative Sell
14.28K
$6.89M
List of latest transactions for each holding click on a transaction to see Dean Schorno's performance on stock
You May Also Like
Dean Schorno insider profile FAQ
What is the percentage of profitable transactions made by Dean Schorno?
The percentage of profitable transactions made by Dean Schorno is 33%.
What is the average return per transaction made by Dean Schorno?
The average return per transaction made by Dean Schorno is -29.90%.
What stocks does Dean Schorno hold?
Dean Schorno holds: GHDX, RIGL stocks.
What was Dean Schorno’s latest transaction?
Dean Schorno latest transaction was an Informative Sell of $14.28K.
What was Dean Schorno's most profitable transaction?
Dean Schorno’s most profitable transaction was an Informative Sell of RIGL stock on February 6, 2023. The return on the trade was 28.60%.
What is Dean Schorno's role in Genomic Health?
Dean Schorno's role in Genomic Health is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.